中文 | English
Return
Total: 1 , 1/1
Show Home Prev Next End page: GO
Author:(Naoki TAKEZAKO)

1.Impact of rituximab and half-dose CHOP as primary therapy for untreated symptomatic Waldenström Macroglobulinemia: review of a combined regimen of rituximab with an alkylating agent.

Naohiro SEKIGUCHI ; Airi HAMANO ; Tomoko KITAGAWA ; Yuya KURIHARA ; Kenichi ITO ; Miwa KURIMOTO ; Kozo WATANABE ; Kazuhiko HIRANO ; Satoshi NOTO ; Kazuaki YAMADA ; Naoki TAKEZAKO

Blood Research 2018;53(2):117-122

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1 , 1/1 Show Home Prev Next End page: GO